Insider Trading activities at China Jo-jo Drugstores, Inc. (CJJD.OB)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of China Jo-jo Drugstores, Inc. (CJJD.OB) since 2009 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at China Jo-jo Drugstores, Inc.. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1413263.

Total stock buying since 2009: $0.
Total stock sales since 2009: $10,000.
Total stock option exercises since 2009: $0.

▪ Recent SEC 13D filings for CJJD.OB
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies

A schedule 13D must be filed with the SEC when a person or group of persons acquires beneficial ownership of more than 5% of China Jo-jo Drugstores, Inc. (CJJD.OB). A schedule 13D/A is an amendment that is filed when there are any material changes in beneficial ownership.


Table 1. Yearly summary of insider stock purchases, sales, and option exercises at China Jo-jo Drugstores, Inc. (CJJD.OB).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2009 0 $0 2,000,000 $10,000 0 $0

Table 2. Monthly summary of insider trading at China Jo-jo Drugstores, Inc. (CJJD.OB).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2009-09 0 $0 2,000,000 $10,000 0 $0

Table 3. Detailed insider trading at China Jo-jo Drugstores, Inc. (CJJD.OB)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2009-09-17 Morita John S. (10% Owner) Sale 1,000,000 .01 5,000
2009-09-17 Yinglong He John (10% Owner) Sale 1,000,000 .01 5,000

Insider trading activities including stock purchases, stock sales, and option exercises of CJJD.OB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of China Jo-jo Drugstores, Inc. (symbol CJJD.OB, CIK number 1413263) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.